Open access · OA
via OpenAlex
Prognostic Value of Blood Epigenetic Biomarkers of Aging in Persons With Well-Controlled HIV-1 Infection
Patricia Martínez-Martín, Andrés Esteban-Cantos, Francisco Jurado, Rocío Montejano, Lucía Gutiérrez-García, Alejandro de Gea Grela, Juan Carlos González, Cristina Marcelo, Alejandro Díez Vidal, María del Mar Arcos-Rueda, Rosa de Miguel Buckley, José Ignacio Bernardino, María Jiménez-González, María Lagarde, José Sanz
Clinical Infectious Diseases · 2025 · ▲ 5 citations
Abstract
BACKGROUND: Epigenetic age acceleration (EAA) predicts morbidity and mortality in the general population, but its prognostic utility in people with human immunodeficiency virus (HIV) (PWH) on suppressive antiretroviral therapy remains unclear. METHODS: Longitudinal observational cohort of 216 PWH with sustained virological suppression (median 6.5 years) recruited from the DUAL-GESIDA trial and La Paz Aging Cohort (Spain). Baseline blood DNA methylation was assessed to evaluate 8 epigenetic clocks, their principal-component (PC) derivatives, and the telomere(definition) length estimator. Over 10 years, we recorded AIDS, serious non-AIDS (SNAEs), and aging-related events. Associations between EAA and outcomes were evaluated by multivariate Cox models. RESULTS: One hundred five participants experienced ≥ 1 event, 162 events recorded in total (1 AIDS event, 65 SNAEs, and 96 aging-related events). A positive EAA by Horvath's clock was associated with a 50% higher risk of aging-related events. Participants with positive EAA according to PC-GrimAge, GrimAge V1-V2, as well as Hannum´s clock experienced more than 2-fold increased risk of SNAEs. Positive EAA by PC-GrimAge and PhenoAge was associated with an increased risk of non-AIDS cancer. Additionally, positive EAA according to GrimAge V1-V2 was linked to a 4-fold increase in all-cause mortality risk. All individuals who died (n = 17) had a baseline DunedinPACE value >1. No associations were found for the composite endpoint or cardiovascular events. CONCLUSIONS: In this preliminary study, GrimAge and PC-GrimAge were associated with increased risk of adverse outcomes in people with well-controlled HIV infection. These findings suggest their potential as long-term health-risk biomarkers, warranting validation in larger cohorts.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1093/cid/ciaf537
- Canonical
- link ↗
- Fetched
- 2026-10-16 MST
Cite this
APA
Martínez-Martín, P., Esteban-Cantos, A., Jurado, F., Montejano, R., Gutiérrez-García, L., Grela, A.D.G., González, J.C., Marcelo, C., Vidal, A.D., Arcos-Rueda, M.D.M., Buckley, R.D.M., Bernardino, J.I., Jiménez-González, M., Lagarde, M., Sanz, J., Ryan, P., Estrada, V., Latorre, L.P., Losa, J.E., & Rodés, B. (2025). Prognostic Value of Blood Epigenetic Biomarkers of Aging in Persons With Well-Controlled HIV-1 Infection. <em>Clinical Infectious Diseases</em>. https://doi.org/10.1093/cid/ciaf537
Vancouver
Martínez-Martín P, Esteban-Cantos A, Jurado F, Montejano R, Gutiérrez-García L, Grela ADG, et al. Prognostic Value of Blood Epigenetic Biomarkers of Aging in Persons With Well-Controlled HIV-1 Infection. Clinical Infectious Diseases. 2025. doi:10.1093/cid/ciaf537.
BibTeX
@article{patricia2025Progno,
title = {Prognostic Value of Blood Epigenetic Biomarkers of Aging in Persons With Well-Controlled HIV-1 Infection},
author = {Patricia Martínez-Martín and Andrés Esteban-Cantos and Francisco Jurado and Rocío Montejano and Lucía Gutiérrez-García and Alejandro de Gea Grela and Juan Carlos González and Cristina Marcelo and Alejandro Díez Vidal and María del Mar Arcos-Rueda and Rosa de Miguel Buckley and José Ignacio Bernardino and María Jiménez-González and María Lagarde and José Sanz and Pablo Ryan and Vicente Estrada and Leire Perez Latorre and Juan Emilio Losa and Berta Rodés and José Ramón Arribas},
journal = {Clinical Infectious Diseases},
year = {2025},
doi = {10.1093/cid/ciaf537},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
European Heart Journal 2026
Citation only
Epigenetic scores and aging clocks capture mortality risk in heart failure
Epigenetics 2025
Open access · CC-BY
GrimAge and GrimAge2 Age Acceleration effectively predict mortality risk: a retrospective cohort study
Cardiovascular Diabetology 2024
Open access · CC-BY
DNA Methylation-derived biological age and long-term mortality risk in subjects with type 2 diabetes
Clinical Epigenetics 2025
Open access · CC-BY
Associations between five indicators of epigenetic age acceleration and all-cause and cause-specific mortality among US adults aged 50 years and older
Odense University Hospital 2020
Open access · US-GOV
Predictive Value of Geriatric Oncology Screening and Geriatric Assessment in Older Patients With Solid Cancers: A Prospective G8 Study
Clinical Epigenetics 2018
Open access · CC-BY